Mkt Cap$2.23T-1.74%
24h Vol$74.28B
BTC Dom56.3%
ETH Dom9.0%
F&G17Extreme Fear
BTC$62,686.00-1.67% ETH$1,666.62-3.16% USDT$0.9987-0.01% BNB$577.36-1.84% USDC$0.9996-0.01% XRP$1.10-1.88% SOL$69.40-3.23% TRX$0.329-1.01% FIGR_HELOC$1.03-0.16% HYPE$61.30-7.24% DOGE$0.0789-3.56% USDS$0.9997+0.00% RAIN$0.0157-2.06% LEO$9.49-0.84% ZEC$413.84-6.89% XLM$0.1911-3.05% BTC$62,686.00-1.67% ETH$1,666.62-3.16% USDT$0.9987-0.01% BNB$577.36-1.84% USDC$0.9996-0.01% XRP$1.10-1.88% SOL$69.40-3.23% TRX$0.329-1.01% FIGR_HELOC$1.03-0.16% HYPE$61.30-7.24% DOGE$0.0789-3.56% USDS$0.9997+0.00% RAIN$0.0157-2.06% LEO$9.49-0.84% ZEC$413.84-6.89% XLM$0.1911-3.05%
News

flu shot

Total Stories
1
Section
flu shot
Moderna's Shares Gain in Premarket After Promising Study Results of New Flu Shot
Market Analysis

Moderna’s Shares Gain in Premarket as New Flu Shot Shows Promising Results

Moderna's experimental flu vaccine demonstrated superior efficacy compared to standard flu vaccines in late-stage trials.

Tim FriesJun 30, 20253 min read